Vycor Medical, Inc. (VYCO)
USD 0.07
(24.05%)
USD 0.07
(24.05%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.27 Million USD | -8.16% |
| 2022 | 1.38 Million USD | -18.02% |
| 2021 | 1.69 Million USD | -2.12% |
| 2020 | 1.73 Million USD | -15.98% |
| 2019 | 2.06 Million USD | -12.33% |
| 2018 | 2.34 Million USD | -4.88% |
| 2017 | 2.47 Million USD | -13.6% |
| 2016 | 2.85 Million USD | -3.58% |
| 2015 | 2.96 Million USD | -22.49% |
| 2014 | 3.82 Million USD | 18.93% |
| 2013 | 3.21 Million USD | -16.83% |
| 2012 | 3.86 Million USD | -27.2% |
| 2011 | 5.31 Million USD | 195.11% |
| 2010 | 1.8 Million USD | 60.85% |
| 2009 | 1.11 Million USD | -29.52% |
| 2008 | 1.58 Million USD | 224.85% |
| 2007 | 488.81 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 294.61 Thousand USD | -10.8% |
| 2024 Q2 | 340.05 Thousand USD | 15.42% |
| 2023 Q4 | 330.28 Thousand USD | 9.46% |
| 2023 Q1 | 296.98 Thousand USD | -8.71% |
| 2023 Q2 | 346.45 Thousand USD | 16.66% |
| 2023 Q3 | 301.74 Thousand USD | -12.91% |
| 2023 FY | 1.27 Million USD | -8.16% |
| 2022 FY | 1.38 Million USD | -18.02% |
| 2022 Q1 | 333.32 Thousand USD | -17.93% |
| 2022 Q2 | 374.41 Thousand USD | 12.33% |
| 2022 Q3 | 355.81 Thousand USD | -4.97% |
| 2022 Q4 | 325.3 Thousand USD | -8.57% |
| 2021 FY | 1.69 Million USD | -2.12% |
| 2021 Q3 | 385.33 Thousand USD | -10.1% |
| 2021 Q4 | 406.14 Thousand USD | 5.4% |
| 2021 Q2 | 428.61 Thousand USD | -9.6% |
| 2021 Q1 | 474.12 Thousand USD | 11.18% |
| 2020 Q3 | 441.74 Thousand USD | 4.4% |
| 2020 Q1 | 468.54 Thousand USD | -9.58% |
| 2020 Q2 | 423.13 Thousand USD | -9.69% |
| 2020 Q4 | 426.45 Thousand USD | -3.46% |
| 2020 FY | 1.73 Million USD | -15.98% |
| 2019 Q3 | 506.45 Thousand USD | -9.28% |
| 2019 FY | 2.06 Million USD | -12.33% |
| 2019 Q1 | 477.3 Thousand USD | -11.14% |
| 2019 Q2 | 558.26 Thousand USD | 16.96% |
| 2019 Q4 | 518.19 Thousand USD | 2.32% |
| 2018 Q1 | 610.3 Thousand USD | 11.21% |
| 2018 FY | 2.34 Million USD | -4.88% |
| 2018 Q2 | 660.32 Thousand USD | 8.2% |
| 2018 Q4 | 537.12 Thousand USD | -0.93% |
| 2018 Q3 | 542.13 Thousand USD | -17.9% |
| 2017 Q3 | 619.34 Thousand USD | -0.45% |
| 2017 FY | 2.47 Million USD | -13.6% |
| 2017 Q4 | 548.78 Thousand USD | -11.39% |
| 2017 Q2 | 622.12 Thousand USD | -8.53% |
| 2017 Q1 | 680.14 Thousand USD | -13.41% |
| 2016 FY | 2.85 Million USD | -3.58% |
| 2016 Q4 | 785.48 Thousand USD | 30.16% |
| 2016 Q1 | 847.62 Thousand USD | 31.53% |
| 2016 Q3 | 603.48 Thousand USD | -3.1% |
| 2016 Q2 | 622.82 Thousand USD | -26.52% |
| 2015 Q1 | 885.17 Thousand USD | 7.02% |
| 2015 FY | 2.96 Million USD | -22.49% |
| 2015 Q3 | 725.77 Thousand USD | 2.2% |
| 2015 Q2 | 710.13 Thousand USD | -19.78% |
| 2015 Q4 | 644.42 Thousand USD | -11.21% |
| 2014 Q2 | 966.38 Thousand USD | -26.1% |
| 2014 Q4 | 827.1 Thousand USD | 14.12% |
| 2014 Q3 | 724.78 Thousand USD | -25.0% |
| 2014 Q1 | 1.3 Million USD | 56.6% |
| 2014 FY | 3.82 Million USD | 18.93% |
| 2013 Q2 | 816.67 Thousand USD | 1.92% |
| 2013 Q4 | 835.04 Thousand USD | 9.3% |
| 2013 Q3 | 764.02 Thousand USD | -6.45% |
| 2013 Q1 | 801.27 Thousand USD | -5.52% |
| 2013 FY | 3.21 Million USD | -16.83% |
| 2012 Q3 | 957.12 Thousand USD | -1.11% |
| 2012 Q2 | 967.85 Thousand USD | -11.6% |
| 2012 Q4 | 848.11 Thousand USD | -11.39% |
| 2012 Q1 | 1.09 Million USD | 3.29% |
| 2012 FY | 3.86 Million USD | -27.2% |
| 2011 Q1 | 905.22 Thousand USD | 50.75% |
| 2011 Q2 | 1.91 Million USD | 111.31% |
| 2011 Q3 | 1.3 Million USD | -31.76% |
| 2011 Q4 | 1.05 Million USD | -18.8% |
| 2011 FY | 5.31 Million USD | 195.11% |
| 2010 Q3 | 341.04 Thousand USD | -31.8% |
| 2010 Q2 | 500.07 Thousand USD | 39.43% |
| 2010 Q1 | 358.65 Thousand USD | -6.6% |
| 2010 FY | 1.8 Million USD | 60.85% |
| 2010 Q4 | 600.47 Thousand USD | 76.07% |
| 2009 FY | 1.11 Million USD | -29.52% |
| 2009 Q2 | 234.04 Thousand USD | -31.56% |
| 2009 Q3 | 159.15 Thousand USD | -32.0% |
| 2009 Q1 | 341.96 Thousand USD | -11.7% |
| 2009 Q4 | 383.99 Thousand USD | 141.27% |
| 2008 Q1 | 484.96 Thousand USD | 0.0% |
| 2008 Q4 | 387.25 Thousand USD | 19.11% |
| 2008 Q3 | 325.11 Thousand USD | -16.76% |
| 2008 FY | 1.58 Million USD | 224.85% |
| 2008 Q2 | 390.59 Thousand USD | -19.46% |
| 2007 FY | 488.81 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -72.203% |
| IR-Med Inc. | 4.89 Million USD | 73.938% |
| Polarean Imaging plc | 12.24 Million USD | 89.582% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 3.41% |
| Avitar, Inc. | 3.56 Million USD | 64.268% |
| AVITA Medical, Inc. | 80.77 Million USD | 98.421% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -81.431% |
| Össur hf. | 396.18 Million USD | 99.678% |
| Zecotek Photonics Inc. | 3.46 Million USD | 63.152% |
| QHSLab, Inc. | 961.65 Thousand USD | -32.632% |
| Wellstar International, Inc. | 1.79 Million USD | 28.932% |
| Össur hf. | 396.18 Million USD | 99.678% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 94.143% |
| Escalon Medical Corp. | 5.25 Million USD | 75.709% |
| Aurora Spine Corporation | 8.65 Million USD | 85.268% |
| BrainsWay Ltd. | 28.01 Million USD | 95.448% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | 86.664% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 96.201% |
| Vivos Inc. | 2.78 Million USD | 54.237% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.878% |
| Kelyniam Global, Inc. | 2.27 Million USD | 43.942% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -25.673% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -192.873% |
| Nanomix Corporation | 8.36 Million USD | 84.757% |
| Theraclion SA | 7.43 Million USD | 82.856% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | 1.477% |
| Positron Corporation | 1 Million USD | -26.624% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 58.994% |
| Lombard Medical, Inc. | 30.29 Million USD | 95.789% |
| ALR Technologies Inc. | 6.33 Million USD | 79.87% |
| Stratec SE | 46.32 Million USD | 97.246% |
| Heart Tronics, Inc. | 14.46 Million USD | 91.179% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -958.247% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -517.9% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 90.987% |
| VMS Rehab Systems, Inc. | 63.63 USD | -2004399.45% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 63.485% |
| Ingen Technologies, Inc. | 1.88 Million USD | 32.236% |
| Odyssey Group International, Inc. | -14.26 Million USD | 108.944% |
| United American Healthcare Corporation | 59 Thousand USD | -2061.802% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -213.009% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -100.959% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 24.777% |
| Urologix, Inc. | 10.09 Million USD | 87.362% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -0.96% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 78.558% |
| SS Innovations International, Inc. | 21.38 Million USD | 94.035% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -453.969% |
| Smith & Nephew plc | 3.46 Billion USD | 99.963% |
| NIOX Group Plc | 22.27 Million USD | 94.275% |
| Fuse Medical, Inc. | 10.35 Million USD | 87.677% |
| Broncus Holding Corporation | 38.15 Million USD | 96.657% |
| Brain Scientific Inc. | 9.66 Million USD | 86.8% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 87.62% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -2001.326% |